Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, informs its shareholders that the ordinary shareholder meeting was held on May 16, 2017 and all resolutions were approved. The extraordinary shareholder meeting convened on first call could not be held as the quorum required by law was not reached.

The shareholders thus are convened on second call for an Extraordinary shareholder meeting on same agenda on Tuesday May 30, 2017 at 2:00 pm CET in the offices of Drakkar D – BuroClub – room Colomb – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.

The documents mentioned in articles R.225-73-1 of the French Code de commerce, including those to be presented at the shareholder meeting, are available on the Company’s website www.nicox.com. These documents are also available to shareholders at the headquarters of the Company.

Shareholders may vote by proxy, by internet or by attending the shareholder meeting in person. A guide explaining how to vote, and notably how to vote by internet, is available on Nicox’s website. Shareholders may also contact the Company’s Investor Relations team at Age2017@nicox.com for any question on the voting process.